Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 9.83% is 15% below its 5-year average of 11.58%, around the middle of its 5-year range (1.99%–16.01%).
9.74% below its 12-month average of 10.89%.
Reported quarterly operating margin; no daily interpolation. Q3 FY2026 (2026-06-30): 13.31%.
OPERATING MARGIN
9.83%
OPERATING MARGIN AVG TTM
10.89%
OPERATING MARGIN AVG 3Y
11.42%
OPERATING MARGIN AVG 5Y
11.58%
OPERATING MARGIN AVG 10Y
10.34%
OPERATING MARGIN AVG 15Y
13.19%
OPERATING MARGIN AVG 20Y
15.20%
CURRENT VS TTM AVG
-9.74%
CURRENT VS 3Y AVG
-13.95%
CURRENT VS 5Y AVG
-15.10%
CURRENT VS 10Y AVG
-4.97%
CURRENT VS 15Y AVG
-25.49%
CURRENT VS 20Y AVG
-35.33%
SECTOR MEDIAN · HEALTHCARE
14.90%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-34.03%
vs the sector median at left
Becton, Dickinson and Company
Market Cap
$49.00B
Operating Margin
9.83%
TTM Avg
10.89%
3Y Avg
11.42%
5Y Avg
11.58%
Market Cap
$48.58B
Operating Margin
28.09%
TTM Avg
26.16%
3Y Avg
28.11%
5Y Avg
28.79%
Market Cap
$43.20B
Operating Margin
11.45%
TTM Avg
5.33%
3Y Avg
-0.33%
5Y Avg
-1.99%
Market Cap
$43.09B
Operating Margin
13.57%
TTM Avg
14.15%
3Y Avg
13.50%
5Y Avg
11.74%
Market Cap
$54.94B
Operating Margin
1.03%
TTM Avg
1.02%
3Y Avg
0.74%
5Y Avg
0.49%
Market Cap
$41.50B
Operating Margin
22.23%
TTM Avg
22.07%
3Y Avg
21.88%
5Y Avg
20.79%
Market Cap
$57.13B
Operating Margin
-158.13%
TTM Avg
-140.72%
3Y Avg
-73.36%
5Y Avg
-52.24%
Market Cap
$39.81B
Operating Margin
32.03%
TTM Avg
30.27%
3Y Avg
29.30%
5Y Avg
28.64%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Becton, Dickinson and Company (BDX) | $49.00B | 9.83% | 10.89% | 11.42% | 11.58% |
| Humana Inc. (HUM)vs › | $49.21B | 1.39% | 1.25% | 2.37% | 3.27% |
| Edwards Lifesciences Corporation (EW)vs › | $48.58B | 28.09% | 26.16% | 28.11% | 28.79% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $43.20B | 11.45% | 5.33% | -0.33% | -1.99% |
| IQVIA Holdings Inc. (IQV)vs › | $43.09B | 13.57% | 14.15% | 13.50% | 11.74% |
| Cardinal Health, Inc. (CAH)vs › | $54.94B | 1.03% | 1.02% | 0.74% | 0.49% |
| Agilent Technologies, Inc. (A)vs › | $41.50B | 22.23% | 22.07% | 21.88% | 20.79% |
| Moderna, Inc. (MRNA)vs › | $57.13B | -158.13% | -140.72% | -73.36% | -52.24% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $39.81B | 32.03% | 30.27% | 29.30% | 28.64% |
| Cencora, Inc. (COR)vs › | $62.57B | 1.30% | 1.08% | 1.06% | 1.09% |
Gross Margin
46.1%
Operating Margin
9.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 13.31% |
| 2026-03-31 | 1.99% |
| 2025-12-31 | 11.31% |
| 2025-09-30 | 11.83% |
| 2025-06-30 | 16.01% |
| 2025-03-31 | 10.36% |
| 2024-12-31 | 8.77% |
| 2024-09-30 | 11.44% |
| 2024-06-30 | 12.06% |
| 2024-03-31 | 14.55% |
| 2023-12-31 | 9.33% |
| 2023-09-30 | 6.86% |
| 2023-06-30 | 11.25% |
| 2023-03-31 | 13.03% |
| 2022-12-31 | 12.76% |
| 2022-09-30 | 10.27% |
| 2022-06-30 | 11.57% |
| 2022-03-31 | 11.87% |
| 2021-12-31 | 14.67% |
| 2021-09-30 | 9.64% |
| 2021-06-30 | 10.68% |
| 2021-03-31 | 8.84% |
| 2020-12-31 | 23.35% |
| 2020-09-30 | 5.33% |
| 2020-06-30 | 9.29% |
| 2020-03-31 | 8.70% |
| 2019-12-31 | 11.86% |
| 2019-09-30 | 2.42% |
| 2019-06-30 | 14.39% |
| 2019-03-31 | 3.24% |
| 2018-12-31 | 21.35% |
| 2018-09-30 | 12.97% |
| 2018-06-30 | 11.97% |
| 2018-03-31 | 4.41% |
| 2017-12-31 | 7.63% |
| 2017-09-30 | 13.99% |
| 2017-06-30 | -7.35% |
| 2017-03-31 | 15.02% |
| 2016-12-31 | 27.75% |
| 2016-09-30 | 2.97% |
| 2016-06-30 | 16.14% |
| 2016-03-31 | 15.19% |
| 2015-12-31 | 11.79% |
| 2015-09-30 | 9.64% |
| 2015-06-30 | 4.39% |
| 2015-03-31 | 14.29% |
| 2014-12-31 | 17.02% |
| 2014-09-30 | 18.26% |
| 2014-06-30 | 20.63% |
| 2014-03-31 | 18.39% |
| 2013-12-31 | 18.76% |
| 2013-09-30 | 3.63% |
| 2013-06-30 | 19.73% |
| 2013-03-31 | 19.05% |
| 2012-12-31 | 20.63% |
| 2012-09-30 | 19.76% |
| 2012-06-30 | 22.67% |
| 2012-03-31 | 19.87% |
| 2011-12-31 | 18.38% |
| 2011-09-30 | 21.37% |
| 2011-06-30 | 22.91% |
| 2011-03-31 | 22.91% |
| 2010-12-31 | 22.43% |
| 2010-09-30 | 20.79% |
| 2010-06-30 | 23.10% |
| 2010-03-31 | 22.99% |
| 2009-12-31 | 22.99% |
| 2009-09-30 | 23.16% |
| 2009-06-30 | 23.72% |
| 2009-03-31 | 20.91% |
| 2008-12-31 | 24.35% |
| 2008-09-30 | 21.70% |
| 2008-06-30 | 21.93% |
| 2008-03-31 | 21.84% |
| 2007-12-31 | 21.26% |
| 2007-09-30 | 20.82% |
| 2007-06-30 | 20.08% |
| 2007-03-31 | 20.18% |
| 2006-12-31 | 14.24% |
| 2006-09-30 | 15.50% |
| 2006-06-30 | 19.66% |
| 2006-03-31 | 17.65% |
| 2005-12-31 | 22.28% |
| 2005-09-30 | 19.04% |
| 2005-06-30 | 18.94% |
| 2005-03-31 | 18.69% |
| 2004-12-31 | 19.46% |
| 2004-09-30 | 20.95% |
| 2004-06-30 | 10.93% |
| 2004-03-31 | 18.31% |
| 2003-12-31 | 14.22% |
| 2003-09-30 | 18.72% |
| 2003-06-30 | 14.97% |
| 2003-03-31 | 17.35% |
| 2002-12-31 | 14.98% |
| 2002-09-30 | 17.85% |
